Studies evaluating the clinical findings in patients with DSP gene mutations reported that pathogenic DSP gene mutations are much more associated with left ventricular cardiomyopathy and a heightened arrhythmia risk, distinct from PKP2, which targets the right ventricle, causing classical ARVC (9). The gene discussed is PKP2; the disease is arrhythmogenic right ventricular cardiomyopathy.